Charles River Laboratories International, Inc. (CRL)
NYSE
Closed
Sep 28, 2026
Day's Range
289.1352 wk Range
145.47Overview - CRL - Charles River Laboratories International, Inc.
Key Statistics
Valuation
Enterprise Value
16.74B
P/E (Trailing)
‪681.33‬
P/E (Forward)
‪22.78‬
PEG Ratio
‪-6.62‬
Price / Sales (TTM)
‪3.49‬
Price / Book
‪4.87‬
EV / EBITDA
‪19.72‬
Profitability
Gross Margin
‪36.18%‬
Profit Margin
‪-5.96%‬
Operating Margin
‪15.11%‬
Return on Assets
‪4.10%‬
Return on Equity
‪-7.51%‬
Ownership
Shares Outstanding
47.72M
Float
47.22M
Short % of Shares Outstanding
‪5.40%‬
Held by Insiders
‪0.47%‬
Held by Institutions
‪122.79%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪276.07‬
200-Day Avg
‪209.97‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Monthly
Analyst Consensus
18 analysts
Average price target
‪$ 301.29‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CRL - Charles River Laboratories International, Inc.
Peers - CRL - Charles River Laboratories International, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
- CRLNYSECharles River Laboratories International, Inc.13.85BMarket Cap+42.96%52-week change681.33P/E (Trailing)‪-5.96%‬Profit Margin
- DHR.PR.ANYSEDanaher Corp1.29TMarket Cap—52-week change213.72P/E (Trailing)‪60.95%‬Profit Margin
- TMONYSEThermo Fisher Scientific Inc.242.11BMarket Cap+16.93%52-week change35.53P/E (Trailing)‪15.03%‬Profit Margin
- ANYSEAgilent Technologies Inc.47.30BMarket Cap+15.60%52-week change33.09P/E (Trailing)‪19.53%‬Profit Margin
- IQVNYSEIQVIA Holdings Inc.42.50BMarket Cap+20.60%52-week change32.16P/E (Trailing)‪8.09%‬Profit Margin
- WATNYSEWaters Corporation41.74BMarket Cap+22.95%52-week change107.38P/E (Trailing)‪3.58%‬Profit Margin
- DIDIANYSEState Street SPDR Dow Jones Industrial Average ETF Trust39.98BMarket Cap+8.66%52-week change20.75P/E (Trailing)—Profit Margin
Profile Summary - CRL - Charles River Laboratories International, Inc.
About
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages. Charles River Laboratories provides research models, discovery services, non-clinical safety assessment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
